Search

Author/Creator Nilsson, Anneli

1. 851 Potent tumor-directed T cell activation and in vivo tumor inhibition induced by a 4–1BB x 5T4 ADAPTIR™ bispecific antibody. (10th December 2020)

Authors:
Nelson, Michelle; Miller, Robert; Nilsson, Anneli; Ljung, Lill; Chunyk, Allison; McMahan, Catherine; Bienvenue, David; Askmyr, Maria; Hernandez-Hoyos, Gabriela; Fritzell, Sara
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A507
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 851 Potent tumor-directed T cell activation and in vivo tumor inhibition induced by a 4–1BB x 5T4 ADAPTIR™ bispecific antibody. (9th November 2020)

Authors:
Nelson, Michelle; Miller, Robert; Nilsson, Anneli; Ljung, Lill; Chunyk, Allison; McMahan, Catherine; Bienvenue, David; Askmyr, Maria; Hernandez-Hoyos, Gabriela; Fritzell, Sara
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A904
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies. Issue 5 (8th March 2019)

Authors:
Irenaeus, Sandra M. M.; Nielsen, Dorte; Ellmark, Peter; Yachnin, Jeffrey; Deronic, Adnan; Nilsson, Anneli; Norlén, Per; Veitonmäki, Niina; Wennersten, Camilla S.; Ullenhag, Gustav J.
Journal:
International journal of cancer
Issue:
Volume 145:Issue 5(2019)
Page Start:
1189
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗